Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 9/11/14  and contains information from public web pages and contributions from the ZoomInfo community.

Chief Executive Officer

BRI Biopharmaceutical Research Inc.
101 - 8898 Heather Street
Vancouver, British Columbia V6P 3S8
Canada

Company Description: BRI Biopharmaceutical Research Inc. is a specialized analytical, bioanalytical and DM/PK contract research organization (CRO) servicing pharmaceutical and...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • Ph.D.
  • Ph.D. , applied medicinal chemistry
  • Undergraduate Pharmacy Program graduate
    University of British Columbia , Canada
  • M.Sc. , applied medicinal chemistry
22 Total References
Web References
Contact Us - Bioanalytical & DM/PK Services
www.bripharm.com, 11 Sept 2014 [cached]
David Kwok, CEO Phone: 604-432-9237 x225 Email: dkwok@bripharm.com
Admet Group--People
www.admetgroup.com, 2 April 2011 [cached]
Management Team | Scientific Team | Scientific Advisory Committee | Albert P. Li, Ph. D., MBA | Arulasanam K. Thilagar, Ph.D. | David Kwok, Ph.D. | Paul E. Kirby, Ph.D. | Clara Faan, B.Sc. | Ping Jiang-Baucom, Ph. D. | Shambhu K. Roy, Ph.D. | Sid Aaron, Ph.D., DABT. | Angeline A. Lazarus, M.D. | David Eastmond, Ph.D.
...
David Kwok, Ph.D.,VP, Drug Development
Dr. Kwok graduated from the Undergraduate Pharmacy Program at the University of British Columbia, Canada, in 1984, followed by his M.Sc. and Ph.D. in applied medicinal chemistry in 1991. He has served in a variety of management and scientific positions at Health Canada from 1991 to 1998, responsible for botanical safety and quality control, antimicrobial drug resistance, and veterinary drug safety laboratory programs. He has been an invited speaker at numerous professional conferences and has contributed to over 30 scientific publications in bioanalytical chemistry applications and drug candidate optimization studies in peer-reviewed journals, poster presentations, and scientific review journals.
David Kwok is a founder and Vice-President of Drug Development at SB ChemTox LLC, Rockville, MD, an analytical chemistry and bioanalytical CRO established with a mission to offer specialized integrative preclinical drug product development services from early discovery studies to preparation of IND package. Dr. Kwok is also the founder of BRI Biopharmaceutical Research Inc., an affiliated CRO based in Vancouver, BC, Canada, focused on analytical and bioanalytical mass spectrometry assays in support of preclinical drug development studies.
Nice Insight | Leadership Awards CRO
www.niceinsight.com, 28 June 2013 [cached]
David Kwok - CEO
SERVICE AREAS: Bioanalytical
Publications - Vivo Drug Metabolisms, Xenograft Efficacy Model
www.bripharm.com, 9 Nov 2006 [cached]
The two key senior staffs are Dr. Albert P. Li and Dr. David Kwok.
...
Dr. David Kwok is an expert in Analytical Chemistry (especially in LC/MS analysis), with over 10 years of industrial experience. Dr. Kwok graduated from his pharmacy program in 1984 and Ph.D. in medicinal chemistry in 1991 from the University of British Columbia, Canada. He served in a variety of management and scientific posts at Health Canada from 1991 to 1998, involving herbal and botanical quality control, antimicrobial drug resistance and veterinary drug safety programs. He has been an invited speaker at numerous professional conferences and has contributed to over 30 scientific publications in bioanalytical chemistry applications and drug candidate optimization studies in peer-reviewed journals, poster presentations, and scientific review journals.
"We can now put forward an ...
www.genengnews.com, 10 May 2013 [cached]
"We can now put forward an insightful approach evaluating DILI using an integrated human in vitro-animal in vivo approach," said David Kwok, Ph.D., CEO, BRI Biopharmaceutical Research. "You still need to have an in vivo animal model such as the one involving animal hepatocytes, given that safety assessment in animals is still a regulatory requirement," he explained.
"At BRI, we advocate the use of the high-content hepatocyte imaging assay in animal hepatocytes (rat, dog, and other relevant species) in support of in vitro/in vivo correlation and justification for a relevant animal species during subsequent IND-enabling preclinical safety evaluation," said Dr. Kwok.
Other People with the name "Kwok":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304